Clinical Trial Update: Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial is evaluating the efficacy and tolerability of adding metformin to standard therapy for multibacillary leprosy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Oxford University Clinical Research Unit Indonesia | Conditions: Leprosy, Leprosy, Multibacillary | Phase 2 | Status: RECRUITING